Gateway's sale of Healthway Medical notes to third parties raises eyebrows
Singapore
AHEAD of Healthway Medical Corporation's (HMC) extraordinary general meeting (EGM) to vote on the second tranche of S$60 million convertible notes, some minority shareholders have raised concerns whether private-equity fund Gateway Partners is there to make a quick buck at their expense.
Questions have risen over why Gateway chose to sell its first tranche of S$10 million in convertible notes to third parties after Lippo-linked Gentle Care has made an offer to buy over these notes at the same price it is offering to pay for each share of HMC.
TRENDING NOW
1 in 5 fresh graduates from autonomous universities still seeking employment: MOM
UOB CEO’s youngest child Grant Wee turns burnout into a wellness business
Cold Storage moves into convenience retail with On The Go, to replace FairPrice at 58 Esso stations
Why copper is becoming Asia’s next AI bottleneck